ORIGINAL RESEARCH article

Front. Cell Dev. Biol.

Sec. Cellular Biochemistry

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1586069

This article is part of the Research TopicResearch in Obesity, Type 2 Diabetes, and Metabolic Syndrome: Cellular Pathways and Therapeutic InnovationsView all 5 articles

Correlation study and full management of metabolic syndrome and sperm DNA fragmentation index, a regional multicentre prospective long term follow-up study from Anhui, China

Provisionally accepted
Dongsheng  MaDongsheng Ma1Jianhong  XiJianhong Xi2*
  • 1Department of Reproductive Medicine, The People''s Hospital Bozhou, Bozhou, China
  • 2Department of Urology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

The final, formatted version of the article will be published soon.

Objective:To investigate the correlation between Metabolic syndrome (Mets) and Sperm DNA fragmentation index (DFI) in men of reproductive age, and to summarise the Mets and metabolic component health management model in men.Results:Intergroup comparison between the observation and control groups in this study showed no statistical difference between the two groups in terms of baseline information and fertility assessment (P>0.05).However, there was statistical difference between the two groups in MetS and metabolic scores (P<0.001).One-way ANOVA showed a statistically significant difference between DFI and MetS scores (P=0.021), and two-way comparisons showed a statistically significant difference between the groups with 0-4 points (P<0.05).There was a moderate-strength positive correlation between metabolic score and DFI by Spearman's correlation analysis (r=0.475, P<0.001).Overall, DFI and MetS were positively associated [OR (95%CI):1.09 (1.07-1.11)] when DFI< 32.26 [OR (95%CI): 1.15(1.12-1.19)].In the overall analysis, the association between MetS and adverse maternity outcomes was statistically significant (OR=1.50, 95% CI: 1.01-2.22, P=0.045).In the sperm DFI subgroup, the association of MetS with adverse maternity outcomes was significant in both DFI≤15 and DFI >30 (15: OR=2.51, 95%CI: 1.01-6.22, P=0.047;>30:OR=2.94, 95%CI: 1.19-7.22, P=0.019), and subgroup analyses of age showed significant association between MetS and adverse maternity outcomes in age > 30 years (OR=1.94, 95% CI: 1.13-3.33, P=0.016).The results of the mediated analysis pathway showed that obesity and hyperlipidaemia lead to sperm DFI abnormalities, which indirectly contribute to adverse maternity outcomes, but it has not been proven that sperm DFI abnormalities contribute to the occurrence of adverse maternity outcomes.The results of multifactorial logistic regression analysis showed that varicocele (OR=1.975), obesity (OR=2.296), hyperlipidaemia (OR=2.422), and Low-HDL (OR=3.654) were the independent risk factors for abnormal sperm DFI.And effective interventions for the group with abnormal sperm DFI could significantly reduce sperm DFI values and metabolic scores (P<0.001). The predictive model has been validated to show positive predictive efficacy and clinical benefit.Conclusion:MetS may lead to abnormal sperm DNA fragmentation indices, which in turn suggests that abnormal sperm DFI due to MetS may be a risk factor for male infertility and spousal dyspareunia, and that effective interventions to reduce sperm DFI values and metabolic scores are necessary and urgent.

Keywords: metabolic syndrome, sperm DNA fragmentation index, male infertility, Obesity, metabolic components

Received: 02 Mar 2025; Accepted: 21 Apr 2025.

Copyright: © 2025 Ma and Xi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jianhong Xi, Department of Urology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more